Glenmark gets USFDA nod for migraine drug

Last Updated: Tuesday, July 2, 2013, 13:46

According to IMS Health, for the 12 month period ending March 2013, Rizatriptan ODT achieved sales of USD 263 million.

USFDA gives nod for Riluzole tablets to Sun Pharma, Glenmark

Last Updated: Friday, June 21, 2013, 20:46

India's Sun Pharmaceutical Industries and Glenmark Generics have got approval from US health regulator to sell generic versions of nervous system disorder treatment drug Riluzole.

Glenmark gets USFDA approval for sclerosis treatment drug

Last Updated: Wednesday, June 19, 2013, 12:34

Drug firm Glenmark Pharmaceuticals on Wednesday said it has received US health regulator's approval to market Riluzole tablets, used in treating nervous system disorder, in the American market.

Glenmark recalls three drugs from US market

Last Updated: Thursday, May 23, 2013, 19:47

A notification issued by US Food and Drug Administration said that the drug major has initiated voluntary recall of its Gabapentin Tablets 600mg.

Glenmark gets USFDA approval for headache drug

Last Updated: Wednesday, May 15, 2013, 15:26

Glenmark's current portfolio consists of 85 products authorised for distribution in the US market.

Drug patent row: HC seeks Glenmark's response by May 22

Last Updated: Friday, April 12, 2013, 15:16

A bench of Justices S Ravindra Bhat and S K Mishra issued a notice to Glenmark and sought its reply by May 22 on the US firm's plea challenging the single judge order.

Drug patent row: HC to hear plea of US firm on Apr 12

Last Updated: Wednesday, April 10, 2013, 14:08

A bench of justices Sanjay Kishan Kaul and Indermeet Kaur took the plea of US pharma major on record and posted it for hearing before another bench on April 12.

Drug patent row: US firm files appeal against interim order

Last Updated: Tuesday, April 9, 2013, 21:51

US pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court challenging its single bench order refusing to grant interim relief to it on a patent row against Indian firm Glenmark Pharmaceuticals.

Patent row: HC refuses interim relief to US drug firm Merck

Last Updated: Friday, April 5, 2013, 15:18

Merck & Co sued Mumbai-based Glenmark for infringing on its patents for two diabetes drugs Januvia and Janumet.

After Novartis, Glenmark in diabetes drug patent violation case

Last Updated: Tuesday, April 2, 2013, 23:03

Pharma firm MSD, the India affiliate of US-based Merck & Co, on Tuesday said it has sued Mumbai-based Glenmark for infringing on its patents for two diabetes drugs Januvia and Janumet.

Glenmark initiates studies to develop new molecule 'GBR 830'

Last Updated: Monday, February 4, 2013, 17:34

Glenmark Pharmaceuticals Monday said it has initiated studies for the development of a new molecule 'GBR 830', which could possibly be used to treat diseases like Arthritis (RA) and bowel disease.